Silexion Therapeutics - Warrants(14/08/2029) Common Stock

As of the most recent data (June 2026), SLXNW shows a common stock of $160K. That compares with $8K in the prior-year period — up 1900.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SLXNW's common stock is now $160K (was $8K) — a 1900.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Silexion Therapeutics - Warrants(14/08/2029) is outperforming or lagging.

Tracking SLXNW's common stock over time shows whether Silexion Therapeutics - Warrants(14/08/2029) is scaling, shrinking, or reshaping that part of the business. The current reading is $160K That compares with $8K in the prior-year period — up 1900.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has Silexion Therapeutics - Warrants(14/08/2029)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $160K) with ownership activity and broader fundamentals.